Abstract
Pancreatic ductal adenocarcinomas (PDAC) represent one of the deadliest cancers
worldwide. Survival is still low due to diagnosis at an advanced stage and resistance to treatment. Herein, we review the main types of liquid biopsy able to help in both prognosis and adaptation of treatments
worldwide. Survival is still low due to diagnosis at an advanced stage and resistance to treatment. Herein, we review the main types of liquid biopsy able to help in both prognosis and adaptation of treatments
Original language | English |
---|---|
Article number | 788869 |
Number of pages | 10 |
Journal | Frontiers in Medicine |
Volume | 8 |
Early online date | 14 Jan 2022 |
DOIs | |
Publication status | E-pub ahead of print - 14 Jan 2022 |
Keywords
- circulating free DNA (cfDNA)
- circulating free microRNAs
- exosomes
- liquid biopsy
- pancreatic ductal adenocarcinoma
- personalized treatment
- prognosis